Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Berri Health is a biotechnology company specializing in the development and production of standardized black raspberry products for clinical research and therapeutic applications. Founded on the pioneering work of Dr. Gary Stoner, the company provides high-quality, freeze-dried black raspberry powder and extracts that are used in numerous NIH-funded clinical trials. These products are investigated for their chemopreventive and anti-inflammatory properties, particularly in the context of oral, esophageal, and colorectal cancers, as well as inflammatory bowel diseases. Berri Health's standardized products allow researchers to study the effects of complex botanical bioactives, such as anthocyanins, on key molecular targets like NF-kB and COX-2. The company is a leader in the field of botanical drug development and nutritional oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Berri Products.